|
1
|
Gupta K, Chakrabarti A, Rana S, Ramdeo R,
Roth BL, Agarwal ML, Tse W, Agarwal MK and Wald DN: Securinine, a
myeloid differentiation agent with therapeutic potential for AML.
PloS One. 6:e212032011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garber K: Energy deregulation: licensing
tumors to grow. Science. 312:1158–1159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu Y, Zhang X, Zhang H, Lan J, Huang G,
Varin E, Lincet H, Poulain L and Icard P: Citrate induces apoptotic
cell death: a promising way to treat gastric carcinoma? Anticancer
Res. 31:797–805. 2011.PubMed/NCBI
|
|
5
|
Agarwal NK, Mueller GA, Mueller C, Streich
JH, Asif AR and Dihazi H: Expression proteomics of acute
promyelocytic leukaemia cells treated with methotrexate. Biochim
Biophys Acta. 1804:918–928. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morshed SR, Tokunaga T, Otsuki S, Takayama
F, Satoh T, Hashimoto K, Yasui T, Okamura M, Shimada J, Kashimata M
and Sakagami H: Effect of antitumor agents on cytotoxicity
induction by sodium fluoride. Anticancer Res. 23:4729–4736.
2003.PubMed/NCBI
|
|
7
|
Verburg M, Renes IB, Einerhand AW, Büller
HA and Dekker J: Isolation-stress increases small intestinal
sensitivity to chemotherapy in rats. Gastroenterology. 124:660–671.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bayley JP and Devilee P: Warburg tumours
and the mechanisms of mitochondrial tumour suppressor genes.
Barking up the right tree? Curr Opin Genet Dev. 20:324–329. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kruspig B, Nilchian A, Orrenius S,
Zhivotovsky B and Gogvadze V: Citrate kills tumor cells through
activation of apical caspases. Cell Mol Life Sci. 69:4229–4237.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Varin E, Allouche S, Lu Y,
Poulain L and Icard P: Effect of citrate on malignant pleural
mesothelioma cells: a synergistic effect with cisplatin. Anticancer
Res. 29:1249–1254. 2009.PubMed/NCBI
|
|
11
|
Cairns RA, Papandreou I, Sutphin PD and
Denko NC: Metabolic targeting of hypoxia and HIF1 in solid tumors
can enhance cytotoxic chemotherapy. Proc Natl Acad Sci USA.
104:9445–9450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fillies T, Werkmeister R, van Diest PJ,
Brandt B, Joos U and Buerger H: HIF1-alpha overexpression indicates
a good prognosis in early stage squamous cell carcinomas of the
oral floor. BMC Cancer. 5:842005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Doe MR, Ascano JM, Kaur M and Cole MD: Myc
posttranscriptionally induces HIF1 protein and target gene
expression in normal and cancer cells. Cancer Res. 72:949–957.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bohuslavová R, Kolář F, Kuthanová L,
Neckář J, Tichopád A and Pavlinkova G: Gene expression profiling of
sex differences in HIF1-dependent adaptive cardiac responses to
chronic hypoxia. J Appl Physiol. 109:1195–1202. 2010.PubMed/NCBI
|
|
16
|
Sitkovsky M and Lukashev D: Regulation of
immune cells by local-tissue oxygen tension: HIF1 alpha and
adenosine receptors. Nat Rev Immunol. 5:712–721. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumar A, Kant S and Singh SM: Novel
molecular mechanisms of antitumor action of dichloroacetate against
T cell lymphoma: Implication of altered glucose metabolism, pH
homeostasis and cell survival regulation. Chem Biol Interact.
199:29–37. 2012. View Article : Google Scholar
|
|
18
|
Priebe A, Tan L, Wahl H, Kueck A, He G,
Kwok R, Opipari A and Liu JR: Glucose deprivation activates AMPK
and induces cell death through modulation of Akt in ovarian cancer
cells. Gynecol Oncol. 122:389–395. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sklar P, Ripke S, Scott LJ, Andreassen OA,
Cichon S, Craddock N, Edenberg HJ, Nurnberger JI Jr, Rietschel M,
Blackwood D, et al: Large-scale genome-wide association analysis of
bipolar disorder identifies a new susceptibility locus near ODZ4.
Nat Genet. 43:977–983. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simon F, Bockhorn M, Praha C, Baba HA,
Broelsch CE, Frilling A and Weber F: Deregulation of HIF1-alpha and
hypoxia-regulated pathways in hepatocellular carcinoma and
corresponding non-malignant liver tissue - influence of a modulated
host stroma on the prognosis of HCC. Langenbecks Arch Surg.
395:395–405. 2010. View Article : Google Scholar
|
|
21
|
Yang W, Xia Y, Ji H, Zheng Y, Liang J,
Huang W, Gao X, Aldape K and Lu Z: Nuclear PKM2 regulates β-catenin
transactivation upon EGFR activation. Nature. 480:118–122.
2011.
|
|
22
|
Luo W and Semenza GL: Pyruvate kinase M2
regulates glucose metabolism by functioning as a coactivator for
hypoxia-inducible factor 1 in cancer cells. Oncotarget. 2:551–556.
2011.PubMed/NCBI
|
|
23
|
Dang CV, Hamaker M, Sun P, Le A and Gao P:
Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl).
89:205–212. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazurek S: Pyruvate kinase type M2: a key
regulator of the metabolic budget system in tumor cells. Int J
Biochem Cell Biol. 43:969–980. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pan JG and Mak TW: Metabolic targeting as
an anticancer strategy: dawn of a new era? Sci STKE.
2007:pe142007.PubMed/NCBI
|
|
26
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: the metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009.PubMed/NCBI
|
|
28
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg’s contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011.
|
|
29
|
Maxwell RE: Calibration of Warburg
Manometers. Science. 110:403–404. 1949. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tennant DA: PK-M2 Makes Cells Sweeter on
HIF1. Cell. 145:647–649. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wittwer JA, Robbins D, Wang F, Codarin S,
Shen X, Kevil CG, Huang TT, Van Remmen H, Richardson A and Zhao Y:
Enhancing mitochondrial respiration suppresses tumor promoter
TPA-induced PKM2 expression and cell transformation in skin
epidermal JB6 cells. Cancer Prev Res (Phila). 4:1476–1484. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koukourakis MI, Giatromanolaki A, Chong W,
Simopoulos C, Polychronidis A, Sivridis E and Harris AL: Amifostine
induces anaerobic metabolism and hypoxia-inducible factor 1 alpha.
Cancer Chemother Pharmacol. 53:8–14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chiavarina B, Whitaker-Menezes D, Migneco
G, Martinez-Outschoorn UE, Pavlides S, Howell A, Tanowitz HB,
Casimiro MC, Wang C, Pestell RG, et al: HIF1-alpha functions as a
tumor promoter in cancer associated fibroblasts, and as a tumor
suppressor in breast cancer cells: Autophagy drives
compartment-specific oncogenesis. Cell Cycle. 9:3534–3551. 2010.
View Article : Google Scholar
|
|
35
|
Zhang X, Varin E, Briand M, Allouche S,
Heutte N, Schwartz L, Poulain L and Icard P: Novel therapy for
malignant pleural mesothelioma based on anti-energetic effect: an
experimental study using 3-Bromopyruvate on nude mice. Anticancer
Res. 29:1443–1448. 2009.PubMed/NCBI
|
|
36
|
Bayet-Robert M, Lim S, Barthomeuf C and
Morvan D: Biochemical disorders induced by cytotoxic marine natural
products in breast cancer cells as revealed by proton NMR
spectroscopy-based metabolomics. Biochem Pharmacol. 80:1170–1179.
2010. View Article : Google Scholar
|
|
37
|
Boros LG, Lee WN and Go VL: A metabolic
hypothesis of cell growth and death in pancreatic cancer. Pancreas.
24:26–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
